A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe

European Radiology

Volumn 16, Issue 5, 2006, Pages 1096-1103

  Träber, Frank ^a   Block, Wolfgang ^a   Freymann, Nikolaus ^a   Gür, Okan ^a   Kucinski, Thomas ^b   Hammen, Thilo ^c   Ende, Gabriele ^d   Pilatus, Ulrich ^e   Hampel, Harald ^f   Schild, Hans H ^a   Heun, Reinhard ^a   Jessen, Frank ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Dementia; Magnetic resonance spectroscopy; Medial temporal lobe; Multicenter; Reproducibility study

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID; WATER;

ADULT; ARTICLE; BRAIN DISEASE; BRAIN METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TEMPORAL LOBE;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CHOLINE; CREATINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TEMPORAL LOBE;

EID: 33645757546     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-0108-y     Document Type: Article

References (35)

1. Bonavita S, Di Salle F, Tedeschi G (1999) Proton MRS in neurological disorders. Eur J Radiol 30:125-131
2. Sijens P, Irwan R, Potze JH, Mostert JP, de Keyser J, Oudkerk M (2005) Analysis of the human brain in primary progressive multiple sclerosis with mapping of the spatial distributions using 1H MR spectroscopy and diffusion tensor imaging. Eur Radiol 15:1686-1693
3. Block W, Jessen F, Träber F et al (2002) Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch Neurol 59:828-834
4. Schuff N, Amend D, Ezekiel F et al (1997) Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 49:1513-1521
5. Jessen F, Block W, Träber F et al (2000) Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55:684-688
6. Jessen F, Block W, Träber F et al (2001) Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 57:930-932
7. Engelhardt E, Moreira DM, Laks J, Marinho VM, Rozenthal M, Oliveira AC (2001) [Alzheimer's disease and magnetic resonance spectroscopy of the hippocampus]. Arq Neuropsiquiatr 59:865-870
8. Block W, Träber F, Kuhl CK et al (1995) [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease]. Röfo Fortschr Geb Röntgenstr Neuen Bildgeb Verfahr 163:230-237
9. Schuff N, Capizzano AA, Du AT et al (2002) Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 58:928-935
10. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD (2002) Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 125:2332-2341
11. Chantal S, Braun CM, Bouchard RW, Labelle M, Boulanger Y (2004) Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Res 1003:26-35
12. Krishnan KR, Charles HC, Doraiswamy PM et al (2003) Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 160:2003-2011
13. Sijens PE, Knopp MV, Brunetti A et al (1995) 1H MR spectroscopy in patients with metastatic brain tumors: A multicenter study. Magn Reson Med 33:818-826
14. Negendank WG, Sauter R, Brown TR et al (1996) Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458
15. Paley M, Cozzonem PJ, Alonso J et al (1996) Multicenter proton magnetic resonance spectroscopy study of neurological complications of AIDS. AIDS Res Hum Retroviruses 12:213-222
16. Lee PL, Yiannoutsos CT, Ernst T et al (2003) A multicenter 1H MRS study of the AIDS dementia complex: Validation and preliminary analysis. J Magn Reson Imaging 17:625-633
17. Holshouser BA, Komu M, Moller HE et al (1995) Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: A multicenter pilot study. Magn Reson Med 33:589-594
18. Chard DT, McLean MA, Parker GJM, MacManus DG, Miller DH (2002) Reproducibility of in vivo metabolite quantification with proton magnetic resonance spectroscopic imaging. J Magn Reson Imaging 15:219-225
19. Komoroski RA, Kotrla KJ, Lemen L, Lindquist D, Diaz P, Foundas A (2004) Brain metabolite concentration ratios in vivo: Multisite reproducibility by single-voxel 1H MR spectroscopy. Magn Reson Imaging 22:721-725
20. Podo F, Henriksen O, Bovee WM, Leach MO, Leibfritz D, de Certaines JD (1998) Absolute metabolite quantification by in vivo NMR spectroscopy: I. Introduction, objectives and activities of a concerted action in biomedical research. Magn Reson Imaging 16:1085-1092
21. Keevil SF, Barbiroli B, Brooks JC et al (1998) Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging 16:1093-1106
22. de Beer R, Barbiroli B, Gobbi G et al (1998) Absolute metabolite quantification by in vivo NMR spectroscopy: III. Multicentre 1H MRS of the human brain addressed by one and the same data-analysis protocol. Magn Reson Imaging 16:1107-1111
23. Bottomley PA (1987) Spatial localization in NMR spectroscopy. Ann NY Acad Sci 508:333-348
24. Vanhamme L, van den Boogaart A, van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35-43
25. van den Boogaart A, van Hecke P, van Huffel S, Graveron-Demilly D, van Ormondt D, de Beer R (1996) MRUI: A graphical user interface for accurate routine MRS data analysis. Proc 13th Ann Meeting ESMRMB Prague, Czech Republic, p.318 (abstract)
26. Bartha R, Drost DJ, Williamson PC (1999) Factors affecting the quantification of short echo in-vivo 1H MR spectra: Prior knowledge, peak elimination, and filtering. NMR Biomed 12:205-216
27. Naressi A, Couturier C, Devos JM et al (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141-152
28. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L (1997) Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 48:878-881
29. Schirmer T, Auer DP (2000) On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain. NMR Biomed 13:28-36
30. Brooks WM, Friedman SD, Stidley CA (1999) Reproducibility of 1H-MRS in vivo. Magn Reson Med 41:193-197
31. Li BSY, Wang H, Gonen O (2003) Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 21:923-928
32. Wellard RM, Briellmann RS, Jennings C, Jackson GD (2005) Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T. Am J Neuroradiol 26:585-590
33. Kantarci K, Jack CR, Xu YC et al (2000) Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 55:210-217
34. Shonk TK, Moats RA, Gifford P et al (1995) Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 195:65-72
35. Moats RA, Ernst T, Shonk TK, Ross BD (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32:110-115